United Therapeutics Corp (NASDAQ:UTHR)

80.69
Delayed Data
As of Sep 13
 +0.87 / +1.09%
Today’s Change
74.31
Today|||52-Week Range
129.59
-25.90%
Year-to-Date

Today’s Trading

Previous close79.82
Today’s open80.33
Day’s range79.98 - 83.14
Volume637,665
Average volume (3 months)665,069
Market cap$3.5B
Data as of 4:00pm ET, 09/13/2019

Growth & Valuation

Earnings growth (last year)+42.53%
Earnings growth (this year)-102.75%
Earnings growth (next 5 years)-6.00%
Revenue growth (last year)-5.65%
P/E ratioNM
Price/Sales2.94
Price/Book1.26

Competitors

 Today’s
change
Today’s
% change
CBPOChina Biologic Produ...-0.51-0.51%
----
MDCOMedicines Co-0.78-1.61%
ALKSAlkermes Plc-0.32-1.41%
Data as of 4:00pm ET, 09/13/2019

Financials

Next reporting dateNovember 4, 2019
EPS forecast (this quarter)$2.53
Annual revenue (last year)$1.6B
Annual profit (last year)$589.2M
Net profit margin36.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Ian Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts